Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Superficial venous ablation · Missouri | Superficial venous ablation · Illinois | |
|---|---|---|
| Surgeons, 2024 | 28 | 97 |
| Medicare fee-for-service cases | 2,393 | 8,273 |
| Growth since 2019 (Medicare FFS) | −9.5%/yr | −2.9%/yr |
| Forecast cases (Medicare FFS) | 2,400 in 2030 | 9,750 in 2030 |
| Forecast growth | +0.1%/yr to 2030 | +2.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.7 | 5.8 |
| Medicare Advantage share | 57% | 47% |
| Out of hospital | 75% (−10 pts since 2019) | 94% (+0 pts since 2019) |
| Cases per surgeon | 85 | 85 |
| Top 10 surgeons' share | 71% | 36% |
| Surgeons growing | 4 | 20 |
| New since the base year | 7 | 29 |
| Likely to stop billing it | 6 by 2026 | 17 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $229 | $589 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.